Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2022

Open Access 01-12-2022 | Research

Complications of injections in conservative treatment of degenerative spine disease: a prospective unicentric study

Authors: Anna Voelker, Markus Pirlich, Christoph-Eckhard Heyde

Published in: BMC Musculoskeletal Disorders | Issue 1/2022

Login to get access

Abstract

Background

Spinal injection has been an accepted part of conservative therapy for degenerative diseases. The drugs used can cause side effects and severe complications. The aim of this study was to determine the occurrence of general side effects (GSE) and complications when performing consecutive different types of spinal injections and to evaluate pain reduction.

Methods

Prospective data evaluation of patients with degenerative spine disease at hospital admission, discharge, and six and 12 weeks after discharge. All patients received a specific injection protocol depending on their symptoms and radiological findings. The injections performed were dorsal sacroiliac joint injections, perineural injections, epidural interlaminar and epidural periradicular injections, and facet joint injections. Potential complications were categorized and recorded as GSE and complications. In addition, the Numerical Analog Scale (NAS) for pain, the Oswestry Disability Index (ODI) were evaluated.

Results

Forty-eight patients were enrolled. There were 282 spinal injections performed. A total of 131 common treatment-related events were recorded. Depending on the type of injection, transient pain at the injection site (32.4–73.5%), radiating pain (9.4–34.7%), and nerve root irritation (2–18.4%) were the most common. One complication with postpuncture syndrome occurred with epidural-interlaminar injection. No persistent neurologic deficits occurred. The highest rate of GSE was observed with periradicular injections (relative frequency (RF) = 0.8), followed by epidural-interlaminar injections (RF = 0.65), least frequently with FJ injections (RF = 0.32). From the time of admission to discharge, NAS scores were significantly decreased and ODI score significantly improved at discharge (p < 0.001), but relapse occurred at the 12-week follow-up.

Conclusions

Various consecutive spinal injections for conservative treatment of degenerative spine diseases are safe and lead to a decrease in pain and improvement in quality of life. GSE are common, but not persistent. Although complications are rare, they can have serious consequences for the patient.
Literature
1.
go back to reference Boswell MV, Colson JD, Sehgal N, et al. A systematic review of therapeutic facet joint interventions in chronic spinal pain. Pain Physician. 2007;10:229–53.CrossRefPubMed Boswell MV, Colson JD, Sehgal N, et al. A systematic review of therapeutic facet joint interventions in chronic spinal pain. Pain Physician. 2007;10:229–53.CrossRefPubMed
8.
go back to reference Everett CR, Baskin MN, Speech D, et al. Flushing as a side effect following lumbar transforaminal epidural steroid injection. Pain Physician. 2004;7:427–9.CrossRefPubMed Everett CR, Baskin MN, Speech D, et al. Flushing as a side effect following lumbar transforaminal epidural steroid injection. Pain Physician. 2004;7:427–9.CrossRefPubMed
10.
go back to reference Kim YU, Karm MH, Cheong Y, et al. Effect of epidural steroid injection on bone mineral density in postmenopausal women according to antiosteoporotic medication use. Pain Physician. 2016;19:389–96.PubMed Kim YU, Karm MH, Cheong Y, et al. Effect of epidural steroid injection on bone mineral density in postmenopausal women according to antiosteoporotic medication use. Pain Physician. 2016;19:389–96.PubMed
12.
go back to reference Manchikanti L, Candido KD, Singh V, et al. Epidural steroid warning controversy still dogging FDA. Pain Physician. 2014;17:E451–74.CrossRefPubMed Manchikanti L, Candido KD, Singh V, et al. Epidural steroid warning controversy still dogging FDA. Pain Physician. 2014;17:E451–74.CrossRefPubMed
13.
go back to reference Goodman BS, Bayazitoglu M, Mallempati S, et al. Dural puncture and subdural injection: a complication of lumbar transforaminal epidural injections. Pain Physician. 2007;10:697–705.CrossRefPubMed Goodman BS, Bayazitoglu M, Mallempati S, et al. Dural puncture and subdural injection: a complication of lumbar transforaminal epidural injections. Pain Physician. 2007;10:697–705.CrossRefPubMed
15.
go back to reference Manchikanti L, Malla Y, Wargo BW, et al. A prospective evaluation of complications of 10,000 fluoroscopically directed epidural injections. Pain Physician. 2012;15:131–40.CrossRefPubMed Manchikanti L, Malla Y, Wargo BW, et al. A prospective evaluation of complications of 10,000 fluoroscopically directed epidural injections. Pain Physician. 2012;15:131–40.CrossRefPubMed
16.
go back to reference Boswell MV, Colson JD, Spillane WF. Therapeutic facet joint interventions in chronic spinal pain: a systematic review of effectiveness and complications. Pain Physician. 2005;8:101–14.PubMed Boswell MV, Colson JD, Spillane WF. Therapeutic facet joint interventions in chronic spinal pain: a systematic review of effectiveness and complications. Pain Physician. 2005;8:101–14.PubMed
17.
go back to reference Fang Z, Yuan C, Cheng L, et al. Comparison of clinical efficacy of epidural injection with or without steroids in the treatment of degenerative disc disease: meta-analysis. Pain Physician. 2022;25:145–60.PubMed Fang Z, Yuan C, Cheng L, et al. Comparison of clinical efficacy of epidural injection with or without steroids in the treatment of degenerative disc disease: meta-analysis. Pain Physician. 2022;25:145–60.PubMed
18.
go back to reference Manchikanti L, Falco FJE, Pampati V, et al. Lumbar interlaminar epidural injections are superior to caudal epidural injections in managing lumbar central spinal stenosis. Pain Physician. 2014;17:E691-702.CrossRefPubMed Manchikanti L, Falco FJE, Pampati V, et al. Lumbar interlaminar epidural injections are superior to caudal epidural injections in managing lumbar central spinal stenosis. Pain Physician. 2014;17:E691-702.CrossRefPubMed
19.
go back to reference Manchikanti L, Cash KA, Pampati V, et al. Transforaminal epidural injections in chronic lumbar disc herniation: a randomized, double-blind, active-control trial. Pain Physician. 2014;17:E489-501.CrossRefPubMed Manchikanti L, Cash KA, Pampati V, et al. Transforaminal epidural injections in chronic lumbar disc herniation: a randomized, double-blind, active-control trial. Pain Physician. 2014;17:E489-501.CrossRefPubMed
25.
go back to reference Manchikanti L. Role of neuraxial steroids in interventional pain management. Pain Physician. 2002;5:182–99.CrossRefPubMed Manchikanti L. Role of neuraxial steroids in interventional pain management. Pain Physician. 2002;5:182–99.CrossRefPubMed
27.
go back to reference Chauhan S, Gaur A, Tripathi M, et al. Unintentional combined epidural and subdural block. Case report Reg Anesth. 1995;20:249–51.PubMed Chauhan S, Gaur A, Tripathi M, et al. Unintentional combined epidural and subdural block. Case report Reg Anesth. 1995;20:249–51.PubMed
31.
go back to reference Chang Chien GC, Candido KD, Knezevic NN. Digital subtraction angiography does not reliably prevent paraplegia associated with lumbar transforaminal epidural steroid injection. Pain Physician. 2012;15:515–23.PubMed Chang Chien GC, Candido KD, Knezevic NN. Digital subtraction angiography does not reliably prevent paraplegia associated with lumbar transforaminal epidural steroid injection. Pain Physician. 2012;15:515–23.PubMed
32.
go back to reference Hong J, Jung S, Chang H. Whitacre needle reduces the incidence of intravascular uptake in lumbar transforaminal epidural steroid injections. Pain Physician. 2015;18:325–31.CrossRefPubMed Hong J, Jung S, Chang H. Whitacre needle reduces the incidence of intravascular uptake in lumbar transforaminal epidural steroid injections. Pain Physician. 2015;18:325–31.CrossRefPubMed
Metadata
Title
Complications of injections in conservative treatment of degenerative spine disease: a prospective unicentric study
Authors
Anna Voelker
Markus Pirlich
Christoph-Eckhard Heyde
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2022
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-022-05970-x

Other articles of this Issue 1/2022

BMC Musculoskeletal Disorders 1/2022 Go to the issue